BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tan LY, Komarasamy TV, Rmt Balasubramaniam V. Hyperinflammatory Immune Response and COVID-19: A Double Edged Sword. Front Immunol 2021;12:742941. [PMID: 34659238 DOI: 10.3389/fimmu.2021.742941] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 12.0] [Reference Citation Analysis]
Number Citing Articles
1 Olivares-Gazca JC, Gale RP, Sánchez-Bonilla D, Gallardo-Pérez MM, Soto-Olvera S, Ruiz-Delgado GJ, Ruiz-Argüelles GJ. SARS-CoV-2-infection in the setting of autotransplants for multiple sclerosis. Hematology 2023;28:2164443. [PMID: 36625336 DOI: 10.1080/16078454.2022.2164443] [Reference Citation Analysis]
2 Amati F, Tonutti A, Huston J, Dela Cruz CS. Glucocorticoid Therapy in COVID-19. Semin Respir Crit Care Med 2023;44:100-17. [PMID: 36646089 DOI: 10.1055/s-0042-1759778] [Reference Citation Analysis]
3 Jergović M, Watanabe M, Bhat R, Coplen CP, Sonar SA, Wong R, Castaneda Y, Davidson L, Kala M, Wilson RC, Twigg HL 3rd, Knox K, Erickson HE, Weinkauf CC, Bime C, Bixby BA, Parthasarathy S, Mosier JM, LaFleur BJ, Bhattacharya D, Nikolich JZ. T-cell cellular stress and reticulocyte signatures, but not loss of naïve T lymphocytes, characterize severe COVID-19 in older adults. Geroscience 2023;:1-16. [PMID: 36633825 DOI: 10.1007/s11357-022-00724-y] [Reference Citation Analysis]
4 Timpau AS, Miftode RS, Costache II, Petris AO, Miftode IL, Gheorghe L, Timpau R, Miftode ID, Prepeliuc CS, Coman I, Anton-Paduraru DT, Tuchilus C, Miftode EG. An Overview of the Impact of Bacterial Infections and the Associated Mortality Predictors in Patients with COVID-19 Admitted to a Tertiary Center from Eastern Europe. Antibiotics (Basel) 2023;12. [PMID: 36671345 DOI: 10.3390/antibiotics12010144] [Reference Citation Analysis]
5 Jergović M, Watanabe M, Bhat R, Coplen CP, Sonar SA, Wong R, Castaneda Y, Davidson L, Kala M, Wilson RC, Twigg HL 3rd, Knox K, Erickson HE, Weinkauf CC, Bime C, Bixby BA, Parthasarathy S, Mosier JM, LaFleur BJ, Bhattacharya D, Nikolich JŽ. T-cell cellular stress and reticulocyte signatures, but not loss of naïve T lymphocytes, characterize severe COVID-19 in older adults. bioRxiv 2022:2022. [PMID: 36597549 DOI: 10.1101/2022.12.21.521463] [Reference Citation Analysis]
6 Robalo Q, De Mot L, Vandromme M, Van Goethem N, Gabrio A, Chung PYJ, Meurisse M, Belgian Collaborative Group On Covid-Hospital Surveillance, Catteau L, Thijs C, Blot K. Association between COVID-19 Primary Vaccination and Severe Disease Caused by SARS-CoV-2 Delta Variant among Hospitalized Patients: A Belgian Retrospective Cohort Study. Vaccines (Basel) 2022;11. [PMID: 36679859 DOI: 10.3390/vaccines11010014] [Reference Citation Analysis]
7 Nekrasova LA, Shmakova AA, Samokhodskaya LM, Kirillova KI, Stoyanova SS, Mershina EA, Nazarova GB, Rubina KA, Semina EV, Kamalov AA. The Association of PLAUR Genotype and Soluble suPAR Serum Level with COVID-19-Related Lung Damage Severity. Int J Mol Sci 2022;23. [PMID: 36555850 DOI: 10.3390/ijms232416210] [Reference Citation Analysis]
8 Jacobs JW, Gisriel SD. SARS-CoV-2-associated warm autoimmune haemolytic anaemia in an immunosuppressed patient: The trend continues. Transfus Med 2022;32:525-6. [PMID: 36251668 DOI: 10.1111/tme.12928] [Reference Citation Analysis]
9 Cuypers Q, Vandebergh V, Stessel B, Callebaut I, Depauw I, Saldien V, Vrancken D. Worsening COVID-19 Disease Course After Surgical Trauma: A Case Series. Anesth Pain Med 2022;In Press. [DOI: 10.5812/aapm-127356] [Reference Citation Analysis]
10 Alla D, Alla SSM, Vempati R, Bhatt H, Sultana Q, Bhatt S, Mohsin T, Siddiqua A. Dengue & COVID-19: A Comparison and the Challenges at Hand. Cureus 2022;14:e31877. [PMID: 36579259 DOI: 10.7759/cureus.31877] [Reference Citation Analysis]
11 Giménez-orenga K, Pierquin J, Brunel J, Charvet B, Martín-martínez E, Perron H, Oltra E. HERV-W ENV antigenemia and correlation of increased anti-SARS-CoV-2 immunoglobulin levels with post-COVID-19 symptoms. Front Immunol 2022;13. [DOI: 10.3389/fimmu.2022.1020064] [Reference Citation Analysis]
12 Parise R, Li YE, Nadar RM, Ramesh S, Ren J, Govindarajulu MY, Moore T, Dhanasekaran M. Health influence of SARS-CoV-2 (COVID-19) on cancer: a review. Acta Biochim Biophys Sin (Shanghai) 2022;54:1395-405. [PMID: 36269132 DOI: 10.3724/abbs.2022147] [Reference Citation Analysis]
13 Jankauskaite L, Malinauskas M, Snipaitiene A. Effect of stimulated platelets in COVID-19 thrombosis: Role of alpha7 nicotinic acetylcholine receptor. Front Cardiovasc Med 2022;9:1037369. [PMID: 36312286 DOI: 10.3389/fcvm.2022.1037369] [Reference Citation Analysis]
14 Stromberg S, Baxter BA, Dooley G, Lavergne SM, Gallichotte E, Dutt T, Tipton M, Berry K, Haberman J, Natter N, Webb TL, Mcfann K, Henao-tamayo M, Ebel G, Rao S, Dunn J, Ryan EP. Relationships between plasma fatty acids in adults with mild, moderate, or severe COVID-19 and the development of post-acute sequelae. Front Nutr 2022;9. [DOI: 10.3389/fnut.2022.960409] [Reference Citation Analysis]
15 Uckun FM, Saeed M, Awili M, Ozercan IH, Qazi S, Lee C, Shibli A, Skolnick AW, Prusmack A, Varon J, Barrera CI, Orhan C, Volk M, Sahin K. Evaluation of the potential of Rejuveinix plus dexamethasone against sepsis. Future Microbiol 2022. [PMID: 36052743 DOI: 10.2217/fmb-2022-0044] [Reference Citation Analysis]
16 Patiño-aldana AF, Ruíz Sternberg ÁM, Pinzón Rondón ÁM, Molano-gonzalez N, Rodriguez Lima DR. Interaction Effect Between Hemoglobin and Hypoxemia on COVID-19 Mortality: an observational study from Bogotá, Colombia. IJGM 2022;Volume 15:6965-6976. [DOI: 10.2147/ijgm.s371067] [Reference Citation Analysis]
17 Badaras I, Laučytė-cibulskienė A. Vascular Aging and COVID-19. Angiology. [DOI: 10.1177/00033197221121007] [Reference Citation Analysis]
18 Yi J, Miao J, Zuo Q, Owusu F, Dong Q, Lin P, Wang Q, Gao R, Kong X, Yang L. COVID-19 pandemic: A multidisciplinary perspective on the pathogenesis of a novel coronavirus from infection, immunity and pathological responses. Front Immunol 2022;13:978619. [DOI: 10.3389/fimmu.2022.978619] [Reference Citation Analysis]
19 Khan SA, Lee TKW. Network pharmacology and molecular docking-based investigations of Kochiae Fructus’s active phytomolecules, molecular targets, and pathways in treating COVID-19. Front Microbiol 2022;13:972576. [DOI: 10.3389/fmicb.2022.972576] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Ramonfaur D, Aguirre-García GM, Diaz-Garza CA, Torre-Amione G, Sanchez-Nava VM, Lara-Medrano R, Ramírez-Elizondo MT, Esparza-Sandoval AC, Ortega-Hernández FJ, Martínez-Reséndez MF. Early increase of serum ferritin among COVID-19 patients is associated with need of invasive mechanical ventilation and with in-hospital death. Infect Dis (Lond) 2022;:1-9. [PMID: 35854671 DOI: 10.1080/23744235.2022.2101691] [Reference Citation Analysis]
21 Tretter F, Marcum J. 'Medical Corona Science': Philosophical and systemic issues: Re-thinking medicine? On the epistemology of Corona medicine. J Eval Clin Pract 2022. [PMID: 35818671 DOI: 10.1111/jep.13734] [Reference Citation Analysis]
22 Brokatzky D, Mostowy S. Pyroptosis in host defence against bacterial infection. Dis Model Mech 2022;15:dmm049414. [PMID: 35801644 DOI: 10.1242/dmm.049414] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
23 Castleman MJ, Stumpf MM, Therrien NR, Smith MJ, Lesteberg KE, Palmer BE, Maloney JP, Janssen WJ, Mould KJ, Beckham JD, Pelanda R, Torres RM. SARS-CoV-2 infection relaxes peripheral B cell tolerance. J Exp Med 2022;219:e20212553. [PMID: 35420627 DOI: 10.1084/jem.20212553] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
24 Declercq J, De Leeuw E, Lambrecht BN. Inflammasomes and IL-1 family cytokines in SARS-CoV-2 infection: From prognostic marker to therapeutic agent. Cytokine 2022. [DOI: 10.1016/j.cyto.2022.155934] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
25 Silva J, Patricio F, Patricio-Martínez A, Santos-López G, Cedillo L, Tizabi Y, Limón ID. Neuropathological Aspects of SARS-CoV-2 Infection: Significance for Both Alzheimer's and Parkinson's Disease. Front Neurosci 2022;16:867825. [PMID: 35592266 DOI: 10.3389/fnins.2022.867825] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Jiménez D, Torres Arias M. Immunouniverse of SARS-CoV-2. Immunol Med 2022;:1-39. [PMID: 35502127 DOI: 10.1080/25785826.2022.2066251] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Fabris M, Del Ben F, Sozio E, Beltrami AP, Cifù A, Bertolino G, Caponnetto F, Cotrufo M, Tascini C, Curcio F. Cytokines from Bench to Bedside: A Retrospective Study Identifies a Definite Panel of Biomarkers to Early Assess the Risk of Negative Outcome in COVID-19 Patients. Int J Mol Sci 2022;23:4830. [PMID: 35563218 DOI: 10.3390/ijms23094830] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Yang X, Rutkovsky AC, Zhou J, Zhong Y, Reese J, Schnell T, Albrecht H, Owens WB, Nagarkatti PS, Nagarkatti M. Characterization of Altered Gene Expression and Histone Methylation in Peripheral Blood Mononuclear Cells Regulating Inflammation in COVID-19 Patients. J Immunol 2022;208:1968-77. [PMID: 35379747 DOI: 10.4049/jimmunol.2101099] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
29 Ely EW, Ramanan AV, Kartman CE, de Bono S, Liao R, Piruzeli MLB, Goldman JD, Saraiva JFK, Chakladar S, Marconi VC, Alatorre-alexander J, Altclas JD, Casas M, Cevolirecio V, Ellerin T, Giovanni Luz K, Goldman JD, Juliani Souza Lima MP, Khan A, Paulin P, Procopio Carvalho AC, Rojas Velasco G, Saraiva JFK, Shawa I, Simon Campos J, Tiffany B, Westheimer Cavalcante A. Efficacy and safety of baricitinib plus standard of care for the treatment of critically ill hospitalised adults with COVID-19 on invasive mechanical ventilation or extracorporeal membrane oxygenation: an exploratory, randomised, placebo-controlled trial. The Lancet Respiratory Medicine 2022;10:327-36. [DOI: 10.1016/s2213-2600(22)00006-6] [Cited by in Crossref: 27] [Cited by in F6Publishing: 40] [Article Influence: 27.0] [Reference Citation Analysis]
30 Ahmed Z, Renart EG, Zeeshan S. Investigating underlying human immunity genes, implicated diseases and their relationship to COVID-19. Per Med 2022. [PMID: 35261286 DOI: 10.2217/pme-2021-0132] [Reference Citation Analysis]
31 Uckun FM, Saeed M, Awili M, Ozercan IH, Qazi S, Lee C, Shibli A, Skolnick AW, Prusmack A, Varon J, Barrera CI, Orhan C, Volk M, Sahin K. Clinical and Non-clinical Proof of Concept Supporting the Development of RJX As an Adjunct to Standard of Care Against Severe COVID-19.. [DOI: 10.1101/2022.02.12.22270748] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Zhang X, Li D, Sun R, Hu X, Song Z, Ni X, Zhu H, Guo T, Qin C, Xiao RP. sRAGE alleviates SARS-CoV-2-induced pneumonia in hamster. Signal Transduct Target Ther 2022;7:36. [PMID: 35110523 DOI: 10.1038/s41392-022-00883-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]